Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P14784 (
IL-2 receptor
)
3,849
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have identified a type I cytokine receptor, which we have termed
novel interleukin receptor
(
NILR
), that is most related to the
IL-2 receptor
beta chain (IL-2Rbeta) and physically adjacent to the IL-4 receptor alpha chain gene on chromosome 16.
NILR
mRNA is most highly expressed in thymus and spleen, and is induced by phytohemagglutinin in human peripheral blood mononuclear cells.
NILR
protein was detected on human T cell lymphotropic virus type I-transformed T cell lines, Raji B cells, and YT natural killer-like cells. Artificial homodimerization of the
NILR
cytoplasmic domain confers proliferation to Ba/F3 murine pro-B cells but not to 32D myeloid progenitor cells or CTLL-2 murine helper T cells. In these latter cells, heterodimerization of IL-2Rbeta and the common cytokine receptor gamma chain (gamma(c)) cytoplasmic domains allows potent proliferation, whereas such heterodimerization of
NILR
with gamma(c) does not. This finding suggests that
NILR
has signaling potential but that a full understanding of its signaling partner(s) is not yet clear. Like IL-2Rbeta,
NILR
associates with Jak1 and mediates Stat5 activation.
...
PMID:Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. 1101 59